Anterior gradient 2 is a novel pro-tumor factor in pancreatic cancer under NF-κB subunit RelA trans-regulation that can be suppressed by eugenic acid

Anterior gradient 2 is a novel pro-tumor factor in pancreatic cancer under NF-κB subunit RelA trans-regulation that can be suppressed by eugenic acid

This study aimed to examine eugenic acid (EA) as an alternative therapeutic approach against pancreatic cancer. The pancreatic cancer xenograft mouse model was employed to determine the impacts of treatment with EA on the growth of tumors. Expressions of NF-κB subunit RelA as well as Anterior gradie...

Full description

Bibliographic Details
Main Authors: Long Huang, Can Yang, Yaodong Wang, Ge Li, Jingjing Pan, Huatian Luo, Zhangwei Wu, Yifeng Tian, Shi Chen, Jiangzhi Chen, Zhixiang Jian
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Pancreatic cancer
Eugenic acid
NF-κB
AGR2
Xenograft
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332220310234

Internet

http://www.sciencedirect.com/science/article/pii/S0753332220310234

Similar Items